Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, started trading on Nasdaq. The successful initial public offering marks the next era of biomanufacturing, based on an idea pioneered by UCLA Professor Emeritus James Bowie over a decade ago – making enzymatic pathways function outside the constraints o ...